• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正常受试者以及患有阿尔茨海默病痴呆症或有患该病风险的患者的血清氨基酸谱

Serum Amino Acid Profiles in Normal Subjects and in Patients with or at Risk of Alzheimer Dementia.

作者信息

Corso Gaetano, Cristofano Adriana, Sapere Nadia, la Marca Giancarlo, Angiolillo Antonella, Vitale Michela, Fratangelo Roberto, Lombardi Teresa, Porcile Carola, Intrieri Mariano, Di Costanzo Alfonso

机构信息

Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy.

Centre for Research and Training in Medicine for Aging, Department of Medicine and Health Sciences "Vincenzo Tiberio," University of Molise, Campobasso, Italy.

出版信息

Dement Geriatr Cogn Dis Extra. 2017 May 4;7(1):143-159. doi: 10.1159/000466688. eCollection 2017 Jan-Apr.

DOI:10.1159/000466688
PMID:28626469
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5471778/
Abstract

BACKGROUND/AIMS: Abnormalities in the plasma amino acid profile have been reported in Alzheimer disease (AD), but no data exist for the prodromal phase characterized by subjective memory complaint (SMC). It was our aim to understand if serum amino acid levels change along the continuum from normal to AD, and to identify possible diagnostic biomarkers.

METHODS

Serum levels of 15 amino acids and 2 organic acids were determined in 4 groups of participants - 29 with probable AD, 18 with mild cognitive impairment (MCI), 24 with SMC, and 46 cognitively healthy subjects (HS) - by electrospray tandem mass spectrometry.

RESULTS

Glutamate, aspartate, and phenylalanine progressively decreased, while citrulline, argi-ninosuccinate, and homocitrulline progressively increased, from HS over SMC and MCI to AD. The panel including these 6 amino acids and 4 ratios (glutamate/citrulline, citrulline/phenylalanine, leucine plus isoleucine/phenylalanine, and arginine/phenylalanine) discriminated AD from HS with about 96% accuracy. Other panels including 20 biomarkers discriminated SMC or MCI from AD or HS with an accuracy ranging from 88 to 75%.

CONCLUSION

Amino acids contribute to a characteristic metabotype during the progression of AD along the continuum from health to frank dementia, and their monitoring in elderly individuals might help to detect at-risk subjects.

摘要

背景/目的:已有报道称阿尔茨海默病(AD)患者血浆氨基酸谱存在异常,但对于以主观记忆主诉(SMC)为特征的前驱期尚无相关数据。我们的目的是了解血清氨基酸水平在从正常到AD的连续过程中是否发生变化,并确定可能的诊断生物标志物。

方法

通过电喷雾串联质谱法测定了4组参与者(29例可能患有AD、18例轻度认知障碍(MCI)、24例有SMC和46例认知健康受试者(HS))血清中15种氨基酸和2种有机酸的水平。

结果

从HS到SMC、MCI再到AD,谷氨酸、天冬氨酸和苯丙氨酸逐渐降低,而瓜氨酸、精氨琥珀酸和高瓜氨酸逐渐升高。包含这6种氨基酸和4种比率(谷氨酸/瓜氨酸、瓜氨酸/苯丙氨酸、亮氨酸加异亮氨酸/苯丙氨酸和精氨酸/苯丙氨酸)的检测组区分AD和HS的准确率约为96%。其他包含20种生物标志物的检测组区分SMC或MCI与AD或HS的准确率在88%至75%之间。

结论

在AD从健康到明显痴呆的连续进展过程中,氨基酸有助于形成特征性代谢型,对老年人进行氨基酸监测可能有助于检测高危人群。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d539/5471778/81bc6ee7a6b4/dee-0007-0143-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d539/5471778/65ce2273f04b/dee-0007-0143-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d539/5471778/dad7f539d262/dee-0007-0143-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d539/5471778/81bc6ee7a6b4/dee-0007-0143-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d539/5471778/65ce2273f04b/dee-0007-0143-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d539/5471778/dad7f539d262/dee-0007-0143-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d539/5471778/81bc6ee7a6b4/dee-0007-0143-g03.jpg

相似文献

1
Serum Amino Acid Profiles in Normal Subjects and in Patients with or at Risk of Alzheimer Dementia.正常受试者以及患有阿尔茨海默病痴呆症或有患该病风险的患者的血清氨基酸谱
Dement Geriatr Cogn Dis Extra. 2017 May 4;7(1):143-159. doi: 10.1159/000466688. eCollection 2017 Jan-Apr.
2
Distinctive Pattern of Serum Elements During the Progression of Alzheimer's Disease.阿尔茨海默病进展过程中血清元素的独特模式。
Sci Rep. 2016 Mar 9;6:22769. doi: 10.1038/srep22769.
3
Plasma amino acid concentrations in patients with amnestic mild cognitive impairment or Alzheimer disease.
Am J Clin Nutr. 2004 Aug;80(2):483-8. doi: 10.1093/ajcn/80.2.483.
4
Increased Plasma Beta-Secretase 1 May Predict Conversion to Alzheimer's Disease Dementia in Individuals With Mild Cognitive Impairment.血浆β-分泌酶 1 水平升高可能预示轻度认知障碍患者向阿尔茨海默病痴呆的转化。
Biol Psychiatry. 2018 Mar 1;83(5):447-455. doi: 10.1016/j.biopsych.2017.02.007. Epub 2017 Mar 27.
5
Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer's pathology in MCI and mild dementia.体重指数降低与 MCI 和轻度痴呆患者的阿尔茨海默病病理的脑脊液标志物有关。
Exp Gerontol. 2017 Dec 15;100:45-53. doi: 10.1016/j.exger.2017.10.013. Epub 2017 Oct 17.
6
Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.血浆β淀粉样蛋白42/β淀粉样蛋白40低比值与轻度认知障碍和阿尔茨海默病的近期风险增加相关。
Arch Neurol. 2007 Mar;64(3):354-62. doi: 10.1001/archneur.64.3.354.
7
Chiral Amino Acid Profiling in Serum Reveals Potential Biomarkers for Alzheimer's Disease.血清中手性氨基酸分析揭示阿尔茨海默病的潜在生物标志物。
J Alzheimers Dis. 2023;94(1):291-301. doi: 10.3233/JAD-230142.
8
Serum Levels of Acyl-Carnitines along the Continuum from Normal to Alzheimer's Dementia.从正常到阿尔茨海默病痴呆连续过程中的酰基肉碱血清水平
PLoS One. 2016 May 19;11(5):e0155694. doi: 10.1371/journal.pone.0155694. eCollection 2016.
9
The Impact of Awareness of and Concern About Memory Performance on the Prediction of Progression From Mild Cognitive Impairment to Alzheimer Disease Dementia.认知和关注记忆表现对从轻度认知障碍到阿尔茨海默病痴呆进展的预测的影响。
Am J Geriatr Psychiatry. 2018 Aug;26(8):896-904. doi: 10.1016/j.jagp.2018.04.008. Epub 2018 May 3.
10
Cerebrospinal fluid biomarkers and memory present distinct associations along the continuum from healthy subjects to AD patients.脑脊液生物标志物与记忆在从健康受试者到 AD 患者的连续体上呈现出不同的关联。
J Alzheimers Dis. 2011;23(2):319-26. doi: 10.3233/JAD-2010-101422.

引用本文的文献

1
Identification of Metabolite Biomarkers Associated With Dietary Patterns in Individuals With Mild Cognitive Impairment and Dementia From Yucatan.尤卡坦半岛轻度认知障碍和痴呆患者中与饮食模式相关的代谢物生物标志物的鉴定
Food Sci Nutr. 2025 Aug 28;13(9):e70859. doi: 10.1002/fsn3.70859. eCollection 2025 Sep.
2
Glutamatergic and GABAergic metabolite levels in Alzheimer's disease: a systematic review and meta-analysis.阿尔茨海默病中谷氨酸能和γ-氨基丁酸能代谢物水平:一项系统评价和荟萃分析。
BMC Neurol. 2025 Aug 26;25(1):344. doi: 10.1186/s12883-025-04375-2.
3
Strain specific effects of probiotic supplementation on serum amino acid profiles in Alzheimer's disease: a randomized, double blind, placebo controlled trial.

本文引用的文献

1
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.临床前阿尔茨海默病:定义、自然史及诊断标准。
Alzheimers Dement. 2016 Mar;12(3):292-323. doi: 10.1016/j.jalz.2016.02.002.
2
Graded perturbations of metabolism in multiple regions of human brain in Alzheimer's disease: Snapshot of a pervasive metabolic disorder.阿尔茨海默病患者大脑多个区域代谢的分级扰动:一种普遍存在的代谢紊乱的快照
Biochim Biophys Acta. 2016 Jun;1862(6):1084-92. doi: 10.1016/j.bbadis.2016.03.001. Epub 2016 Mar 5.
3
Alzheimer's disease.
益生菌补充剂对阿尔茨海默病血清氨基酸谱的菌株特异性影响:一项随机、双盲、安慰剂对照试验。
Sci Rep. 2025 Aug 15;15(1):29924. doi: 10.1038/s41598-025-15355-4.
4
Exploring differences in circulating metabolites of females and males with Alzheimer's disease.探索患有阿尔茨海默病的女性和男性循环代谢物的差异。
J Cereb Blood Flow Metab. 2025 May 16:271678X251340513. doi: 10.1177/0271678X251340513.
5
Alterations of amino acids in older adults with Alzheimer's Disease and Vascular Dementia.患有阿尔茨海默病和血管性痴呆的老年人氨基酸的变化。
Amino Acids. 2025 Jan 18;57(1):10. doi: 10.1007/s00726-024-03442-1.
6
Accelerated cognitive aging in chronically infected HIV-1 positive individuals despite effective long-term antiretroviral therapy.尽管接受了有效的长期抗逆转录病毒治疗,但慢性感染 HIV-1 的个体仍会加速认知老化。
Metab Brain Dis. 2024 Nov 21;40(1):32. doi: 10.1007/s11011-024-01458-w.
7
Quantitative Imaging of Regional Cerebral Protein Synthesis in Clinical Alzheimer's Disease by [C]Leucine PET.利用[C]亮氨酸正电子发射断层扫描对临床阿尔茨海默病患者脑区蛋白质合成进行定量成像
Mol Imaging Biol. 2024 Dec;26(6):977-985. doi: 10.1007/s11307-024-01965-3. Epub 2024 Nov 20.
8
Comparative Analysis of Serum Amino Acid Profiles in Patients with Myasthenia Gravis and Multiple Sclerosis.重症肌无力和多发性硬化症患者血清氨基酸谱的比较分析
J Clin Med. 2024 Jul 12;13(14):4083. doi: 10.3390/jcm13144083.
9
Metabolomics-based search for lung cancer markers among patients with different smoking status.基于代谢组学的不同吸烟状态肺癌患者标志物研究。
Sci Rep. 2024 Jul 4;14(1):15444. doi: 10.1038/s41598-024-65835-2.
10
Role of the Gut Bacteria-Derived Metabolite Phenylacetylglutamine in Health and Diseases.肠道细菌衍生代谢物苯乙酰谷氨酰胺在健康与疾病中的作用
ACS Omega. 2024 Jan 8;9(3):3164-3172. doi: 10.1021/acsomega.3c08184. eCollection 2024 Jan 23.
阿尔茨海默病。
Lancet. 2016 Jul 30;388(10043):505-17. doi: 10.1016/S0140-6736(15)01124-1. Epub 2016 Feb 24.
4
Blood metabolite markers of preclinical Alzheimer's disease in two longitudinally followed cohorts of older individuals.两个纵向随访的老年人群队列中临床前阿尔茨海默病的血液代谢物标志物。
Alzheimers Dement. 2016 Jul;12(7):815-22. doi: 10.1016/j.jalz.2015.12.008. Epub 2016 Jan 21.
5
Unbiased Metabolomic Investigation of Alzheimer's Disease Brain Points to Dysregulation of Mitochondrial Aspartate Metabolism.阿尔茨海默病大脑的无偏代谢组学研究表明线粒体天冬氨酸代谢失调。
J Proteome Res. 2016 Feb 5;15(2):608-18. doi: 10.1021/acs.jproteome.5b01020. Epub 2016 Jan 12.
6
Novel Physiological Functions of Branched-Chain Amino Acids.支链氨基酸的新生理功能
J Nutr Sci Vitaminol (Tokyo). 2015;61 Suppl:S112-4. doi: 10.3177/jnsv.61.S112.
7
A novel approach for LC-MS/MS-based chiral metabolomics fingerprinting and chiral metabolomics extraction using a pair of enantiomers of chiral derivatization reagents.一种基于 LC-MS/MS 的手性代谢组学指纹图谱分析和手性代谢组学提取的新方法,使用一对手性衍生试剂的对映异构体。
Anal Chim Acta. 2015 Oct 22;898:73-84. doi: 10.1016/j.aca.2015.10.010.
8
Alzheimer's Disease Cerebrospinal Fluid and Neuroimaging Biomarkers: Diagnostic Accuracy and Relationship to Drug Efficacy.阿尔茨海默病脑脊液和神经影像生物标志物:诊断准确性及与药物疗效的关系
J Alzheimers Dis. 2015;46(4):817-36. doi: 10.3233/JAD-150238.
9
Evolving Evidence for the Value of Neuroimaging Methods and Biological Markers in Subjects Categorized with Subjective Cognitive Decline.神经影像学方法和生物标志物在被归类为轻度认知功能障碍的受试者中的价值的不断发展的证据。
J Alzheimers Dis. 2015 Sep 24;48 Suppl 1:S171-91. doi: 10.3233/JAD-150202.
10
MetaboAnalyst 3.0--making metabolomics more meaningful.MetaboAnalyst 3.0——让代谢组学更具意义。
Nucleic Acids Res. 2015 Jul 1;43(W1):W251-7. doi: 10.1093/nar/gkv380. Epub 2015 Apr 20.